BMC Medical Genomics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2021-10-01 sunrise19890224

审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0
经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。

94 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2022-06-24 ms6000000521951262

请问新系统怎么联系编辑啊？editor invited20多天了

53 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2021-07-07 121dbfacm23暂无昵称

一直在quality check in progress咋回事

106 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2021-04-12 145a1bf9m78暂无昵称

12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。

79 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2023-03-12 ms9000000792208563 来自广东省

朋友们，技术审查需要多久呀

41 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2022-05-13 ms7000000024233891

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：生信
经验分享：生信投研究文章还是数据库文章啊？

72 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2021-10-12 ms6000002017808678

生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2020-05-01 121dbfacm23暂无昵称

这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表::
怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表:
怎么会这么久?我也是你这个状态，13天了

烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了

113 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2023-06-12 ms9000001377282776 来自广东省

还接受纯生信吗

47 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1056694, encodeId=be301056694c3, content=审稿速度:12.0 | 投稿命中率:5.0 | 版面费用:2500.0 经验分享：这个杂志巨坑！！1 投稿系统还经常登陆不进去。。。。无语。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Fri Oct 01 07:23:42 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228508, encodeId=98451228508c5, content=请问新系统怎么联系编辑啊？editor invited20多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74a35605511, createdName=ms6000000521951262, createdTime=Fri Jun 24 21:16:00 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997081, encodeId=44fc99e0813f, content=一直在quality check in progress咋回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Wed Jul 07 11:19:11 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956106, encodeId=b1759561062d, content=12月22投稿，1月13外审，4.9号返修（小修），目前等主编意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=718d5075825, createdName=145a1bf9m78暂无昵称, createdTime=Mon Apr 12 10:08:22 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1219478, encodeId=df5f12194e8c7, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：生信 经验分享：生信投研究文章还是数据库文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d568144781, createdName=ms7000000024233891, createdTime=Fri May 13 22:28:51 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059888, encodeId=bd431059888d7, content=生信加少量免疫组化验证，被拒稿多次，不知这次如何？祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7705451174, createdName=ms6000002017808678, createdTime=Tue Oct 12 18:11:04 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590040, encodeId=a0bf59004048, content=这个杂志很坑，之前一审4个月，大修，二审又是4个月，换了编辑和审稿人，还在等结果，已经陷进去了，着急毕业的不要投烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了烽火很忙 2020-04-20 00:00:00 发表: 怎么会这么久?我也是你这个状态，13天了, beContent=烽火很忙 2020-04-20 发表:: 怎么会这么久?我也是你这个状态，13天了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/20079c52886593c3206610b559e51f7f.jpg, createdBy=1cdd2287566, createdName=121dbfacm23暂无昵称, createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=)]

2021-05-17 aipeter9194

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：心血管
经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！

76 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务